PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2022.02492022284802-805Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitationsSoon Sun Kim, Jae Youn Cheonghttp://e-cmh.org/upload/pdf/cmh-2022-0249.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2022.0249, http://e-cmh.org/upload/pdf/cmh-2022-0249.pdf
Clinical and Molecular Hepatology10.3350/cmh.2022.03752023291185-187Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahnhttp://e-cmh.org/upload/pdf/cmh-2022-0375.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2022.0375, http://e-cmh.org/upload/pdf/cmh-2022-0375.pdf
Clinics in Liver Disease10.1016/j.cld.2004.04.012200483619-638Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver diseaseAnna Mae Diehlhttps://api.elsevier.com/content/article/PII:S108932610400042X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S108932610400042X?httpAccept=text/plain
Atherosclerosis Supplements10.1016/s1567-5688(02)80070-820023279Insulin resistance in nonalcoholic fatty liver diseasehttps://api.elsevier.com/content/article/PII:S1567568802800708?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1567568802800708?httpAccept=text/plain
Nutrients10.3390/nu9040387201794387Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New TreatmentsHironori Kitade, Guanliang Chen, Yinhua Ni, Tsuguhito Otahttp://www.mdpi.com/2072-6643/9/4/387/pdf
Hepatology10.1002/hep.256772012562788-789Diagnostic accuracy of adipose insulin resistance index and visceral adiposity index for progressive liver histology and cardiovascular risk in nonalcoholic fatty liver diseaseGiovanni Musso, Maurizio Cassader, Roberto Gambinohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.25677, http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.25677/fullpdf
Clinics in Liver Disease10.1016/j.cld.2004.04.006200483575-594Insulin resistance and the pathogenesis of nonalcoholic fatty liver diseaseJayanta Choudhury, Arun J. Sanyalhttps://api.elsevier.com/content/article/PII:S1089326104000364?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1089326104000364?httpAccept=text/plain
Nonalcoholic Fatty Liver Disease - An Update10.5772/intechopen.812972019Insulin Therapy and Autoimmune Disease with Relevance to Non Alchoholic Fatty Liver DiseaseIan James Martinshttp://www.intechopen.com/download/pdf/63818
Nutrition Research10.1016/j.nutres.2013.11.0052014342143-148Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patientsFaezeh Askari, Bahram Rashidkhani, Azita Hekmatdoosthttps://api.elsevier.com/content/article/PII:S0271531713002728?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0271531713002728?httpAccept=text/plain
Hepatology10.1002/hep.2266220084862088-2088Risk of severe liver disease in nonalcoholic fatty liver disease: Role of insulin resistanceAnna Ludovica Fracanzani, Luca Valenti, Silvia Fargionhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.22662, http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.22662/fullpdf